Renaissance Technologies’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-26,200	Closed	-$1.8M	–	3281
2014 Q3	$1.8M	Buy	+26,200	New	+$1.8M	﹤0.01%	1726
2013 Q3	–	Sell	-5,701	Closed	-$239K	–	3076
2013 Q2	$239K	Buy	+5,701	New	+$239K	﹤0.01%	2477